Table 3.
Variable | Coefficient | Standard Error | p-Value | Odds Ratio | 95% Confidence Interval |
---|---|---|---|---|---|
IDO presence in IF | 1.7464 | 0.4780 | 0.0003 | 5.7341 | (2.2470, 14.6324) |
Recipient’s sex 1 | 0.6064 | 0.4825 | 0.2088 | 1.8338 | (0.7123, 4.7212) |
HLA MM >3 2 | −0.7089 | 0.4334 | 0.1019 | 0.4922 | (0.2105, 1.1509) |
PRA >50% 3 | 0.0608 | 0.9684 | 0.9499 | 1.0627 | (0.1593, 7.0909) |
CIT >20 h 4 | 0.8753 | 0.4406 | 0.0469 | 2.3997 | (1.0119, 5.6906) |
Living donor | 0.4948 | 1.0903 | 0.6499 | 1.6402 | (0.1936, 13.8971) |
Proteinuria > 0.5 g 5 | −0.2138 | 0.4135 | 0.6050 | 0.8075 | (0.3591, 1.8159) |
DGF 6 | 0.4000 | 1.2219 | 0.6050 | 1.4918 | (0.1360, 16.3618) |
Glomerulonephritis | −0.3415 | 0.4410 | 0.4387 | 0.7107 | (0.2994, 1.6869) |
Tacrolimus | −1.3162 | 0.7772 | 0.0904 | 0.2682 | (0.0585, 1.2302) |
Cyclosporin | −0.8994 | 0.7818 | 0.2500 | 0.4068 | (0.0879, 1.8830) |
Constant | −0.5004 | 0.9398 | 0.5944 |
1 For purposes of the analysis: 1 = male, 0 = female; 2 Human leukocyte antigen mismatches, more than 3; 3 Panel-reactive antibodies, more than 50%; 4 Cold ischemia time, more than 20 h; 5 Proteinuria larger than 0.5 g; 6 Delayed graft function.